FUS and amyotrophic lateral sclerosis: Our results show that FUS-binding rG4 can mitigate FUS aggregation and have the potential to be developed as therapeutics for FUS-ALS/FTD30; thus, we sought to further enhance the activity of RNA inhibitors by enhancing their G4-forming capability.